Betaine Other names: Betaine hydrochloride Trimethylglycine

Molecular mass: 117.146 g/mol  PubChem compound: 247

Therapeutic indications

Betaine is indicated for:

Homocystinuria

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Adjunctive treatment of homocystinuria, involving deficiencies or defects in:

  • cystathionine beta-synthase (CBS),
  • 5,10-methylene-tetrahydrofolate reductase (MTHFR),
  • cobalamin cofactor metabolism (cbl).

Betaine should be used as supplement to other therapies such as vitamin B6 (pyridoxine), vitamin B12 (cobalamin), folate and a specific diet.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2019: CYSTADANE Powder for oral solution
Summary of Product Characteristics (SPC) 2024: CYSTADANE Oral powder
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈